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Abstract: The fungi associated with marine algae are prolific sources of metabolites with high
chemical diversity and bioactivity. In this study, we investigated culture-dependent fungal
communities associated with the Baltic seaweed Fucus vesiculosus. Altogether, 55 epiphytic and
endophytic fungi were isolated and identified. Twenty-six strains were selected for a small-scale
One-Strain-Many-Compounds (OSMAC)-based fermentation in four media under solid and liquid
culture regimes. In total, 208 fungal EtOAc extracts were tested for anticancer activity and general
cytotoxicity. Ten most active strains (i.e., 80 extracts) were analyzed for their metabolome by molecular
networking (MN), in-silico MS/MS fragmentation analysis (ISDB–UNPD), and manual dereplication.
Thirty-six metabolites belonging to 25 chemical families were putatively annotated. The MN clearly
distinguished the impact of culture conditions in chemical inventory and anticancer activity of the
fungal extracts that was often associated with general toxicity. The bioactivity data were further
mapped into MN to seek metabolites exclusively expressed in the active extracts. This is the first
report of cultivable fungi associated with the Baltic F. vesiculosus that combined an OSMAC and an
integrated MN-based untargeted metabolomics approaches for efficient assessment and visualization
of the impact of the culture conditions on chemical space and anticancer potential of the fungi.
Keywords: Marine fungi; Fucus vesiculosus; OSMAC; molecular network; metabolomics;
dereplication; bioactivity mapping
1. Introduction
Marine fungi are found in all habitats and make a significant contribution to marine environments,
e.g., by decomposition of substrates and animal remains. Marine fungi are regarded as saprotrophs,
parasites, or symbionts (epiphytic an endophytic), as a consequence of the evolution of fungal cell
biology and feeding strategies [1–3]. Recent culture-dependent studies reveal that fungi establish a
symbiotic association with marine macroalgae (seaweeds) [1–3]. The sedentary lifestyle and the lack
of an immune system have led to the evolution of a seaweed holobiont, in which macroalga and its
associated microbiota, including fungi, jointly exercise to enhance the tolerance to abiotic and biotic
stresses [4]. The algicolous fungi have been shown to produce diverse types of secondary metabolites,
presumably contributing to the fitness of its host. Some of these metabolites have demonstrated
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bioactivities, e.g., antioxidant, antimicrobial, and cytotoxic [5–7] that are beneficial to human health.
A prominent example is halimide, a diketopiperazine obtained from an Aspergillus sp. isolated from
the green alga Halimeda copiosa [8]. Plinabulin (NPI-2358) is a synthetic tert-butyl analog of halimide
and the only marine fungal metabolite-based compound that has entered clinical trials (currently in
Phase III) to date [9]. This clearly highlights the potential of seaweed-derived fungi as a valuable
source for discovery of anticancer lead compounds.
Recent bioinformatic approaches in the genomics field points out a significant discrepancy
between the number of secondary metabolite biosynthetic gene clusters (BGCs) and the actual
number of chemically characterized compounds obtained from microorganisms. This stems from
the so-called ‘silent’ or ‘cryptic’ BGCs that are not expressed under standard laboratory conditions
due to a lack of essential natural stimuli for activation of secondary metabolite BGCs [10]. Hence,
fermentation of microorganisms in artificial laboratory conditions represents a major limitation in
microbial drug discovery. Culture-based strategies such as OSMAC (One-Strain-Many-Compounds)
or co-cultivation are vital to evoke the expression of silent BGCs to produce new compounds [11].
The OSMAC approach is highly efficient for induction of chemical diversity by variation of cultivation
parameters [12]. It has been successfully applied to stimulate the production of several new marine
fungal secondary metabolites, exemplified by lajollamide A, a new pentapeptide produced by the
marine green alga-derived fungus Asteromyces cruciatus [13]. This observation, in addition to numerous
other OSMAC-based cultivation studies on microorganisms, suggest that variation of culture conditions
is a promising approach for enhancing the chemical space of alga-derived fungi.
MS/MS based Global Natural Products Social Molecular Networking (GNPS) is a platform,
which enables rapid and automated mass spectral mining of large number of samples. It groups
similar compounds based on similarities of their MS/MS fragmentation patterns and links known
and unknown compounds belonging to the same molecular family in networks [14]. This approach
not only substantially accelerates dereplication capabilities and enhances annotation rates, but also
delivers more in-depth information on chemical inventory of biological organisms [15]. Integration of
MN with in-silico fragmentation pattern database (Universal Natural Product Database (ISDB–UNPD))
further speeds up the tedious dereplication processes [16]. A few recent studies have used molecular
networks (MN) for optimizing the culture conditions and the extraction methods for bacterial natural
products [17]. MN also offers the possibility to map additional information over the network.
The integration of bioactivity data of crude extracts and fractions obtained therefrom with MN is
gaining popularity for prioritization of bioactive extracts and targeted isolation of bioactive metabolites
from botanical sources [18].
The canopy-forming seaweed Fucus vesiculosus L. (bladder wrack) is the most-widespread brown
alga in the shallow coastal regions of the Baltic Sea [19]. It serves as a primary producer providing
food and shelter for marine animals [20]. Previous studies conducted on this seaweed indicate its rich
chemistry and various bioactivities [21]. In a recent study, we investigated seasonal variations in the
metabolome of the Baltic Sea F. vesiculosus and its impact on antioxidant, anticancer and antimicrobial
activity profile of the F. vesiculosus extracts [22]. However, the associated microbiota of this seaweed or
their biotechnological potential has remained poorly investigated. The fungi derived from the North
Atlantic F. vesiculosus were tested for antibacterial and antifungal activity [6,7]. An isobenzofuranone
derivative with antioxidative activity was reported from an Epicoccum sp. isolated from the North Sea
F. vesiculosus [23]. The present study aimed at identification of cultivable fungal communities associated
with the Baltic F. vesiculosus. By using an OSMAC approach, the isolated epi- and endophytic fungi
were grown in, altogether, eight solid and liquid-based culture media. The generated extracts were
tested for their anticancer and cytotoxic properties and the selected ones were dereplicated by an
untargeted LC-MS/MS-based molecular network using automated (GNPS and ISDB-UNPD) [14,16]
and classical manual dereplication methods. The UPLC-MS/MS based MN revealed different culture
conditions to lead to significant differences in chemical inventory and bioactivity of the extracts.
The bioactivity data combined with MN allowed the detection of specific metabolites in the anticancer
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or toxic extracts. This is the first study on fungi associated with the Baltic Sea F. vesiculosus applying an
untargeted metabolomics study integrated with OSMAC and bioactivity mapping.
2. Results
2.1. Isolation of Fungi
In total, 87 fungal strains were obtained (Table S1). Of which, 55 strains were isolated and
identified from F. vesiculosus collected at Kiel Fjord (Baltic Sea, Germany), while 32 fungi originated
from its surrounding environment, i.e.,—sediment (30 isolates) and seawater (2 isolates) controls.
Four solid media (indicated by an “S” in the medium name), i.e., modified Wickerham medium
(WM-S), Potato Dextrose medium (PDM-S), Glucose Yeast Peptone medium (GYP-S), and Glucose
Casein medium (GCM-S) were used for their isolation. The highest number of fungal isolates was
retrieved from WM-S medium (21 isolates), followed by PDM-S (15 isolates), GCM-S (10 isolates), and
GYP-S (9 isolates) (Figure 1A and Figure S1). Overall, 11 epiphytic and 44 endophytic fungi were
obtained from algal thalli after surface sterilization (Figure 1B). Sanger sequencing of the PCR-amplified
ITS1-5.8S rRNA gene-ITS2 region allowed identification of 39 Penicillium sp. that constituted the
largest fraction (71%) of the fungi. In general, a considerable fungal diversity was obtained with
10 strains belonging to seven fungal genera (identified at the genus level). Six isolates were identified
only to a higher taxonomic (i.e., order) level (Figure 2). Penicillium was the predominant genus
in both endophytic and epiphytic fungi. Gibellulopsis sp. was isolated from both endophytic and
epiphytic communities. The endophytic fungi showed a four-fold higher abundance (44 isolates) and
represented by five specific genera, i.e., Acremonium, Trichoderma, Cadophora, Wallemia, and Emericellopsis
(Figure 3A). The media used had a great impact on the diversity of the isolated fungi. For example,
four fungal genera (Acremonium, Fusarium, Trichoderma and Wallemia) were exclusively isolated from
WM-S medium (Figure S2A). Other media also produced unique isolates, e.g., Cadophora sp. was
only retrieved from GYP-S medium (Figure S2B). Both Emericellopsis sp. (WM-S and PDM-S, Figure
S2A,C) and Gibellulopsis sp. were isolated from two different media (WM-S and GCM-S, Figure
S2A,D). Penicillium species were obtained from all media, with PDM-S and GCM-S yielding the highest
numbers (14 and 9 isolates, respectively) (Figure S2C,D).
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Figure 1. The number of identified fungal isolates from Fucus vesiculosus. (A) The number of fungal
strains isolated from single solid medium (S). WM-S = modified Wickerham medium, PDM-S: Potato
Dextrose medium, GCM-S; Glucose Casein mediu , GYP-S; and Glucose Yeast Peptone medium.
(B) The origin of fungi from F. vesiculosus microhabitats.
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Figure 2. Taxonomical diversity of 55 fungal genera isolated from F. vesiculosus (excluding sediment
and seawater). Strains that were not identified to genus level were indicated with ‘Higher taxa’.
The sediment control sample yielded 30 fungal strains, while only two isolates were retrieved
from the seawater (Figure 3A). The genus Penicillium was also dominant among sediment isolates,
accounting for 67% of the isolated strains (20 out of 30), followed by Fusarium sp. (5 isolates).
Three genera, Phoma, Cladosporium, and Stereum were represented by one species each in sediment
samples. Two other sediment-derived strains were only identified at order level (Figure 3A, Table S1).
The seawater control yielded one Penicillium sp. and one Candida sp. Figure 3A depicts the co parative
diversity of fungal isolates from F. vesiculosus and its surrounding habitats.
Several fungal genera, i.e., Acremonium, Gibellulopsis, Trichoderma, Wallemia, Cadophora, and
Emericellopsis were exclusive to F. vesiculosus. The fungal communities isolated from different
origins were compared by a 2D MDS plot to visualize their similarity (Figure 3B). All Fucus-derived
fungal communities (Fucus-epi and Fucus-endo in Figure 3B) clustered more closely, showing a clear
differentiation to those deriving from seawater and sediment controls.
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2.2. OSMAC Cultivation, Extraction and Anticancer Assays
Twenty-three endophytic and three epiphytic fungal strains (Table 1) deriving from F. vesiculosus
thalli were selected for subsequent small-scale fermentation using an OSMAC approach. The strain
selection criteria were: (i) genetic diversity at genus or order level and (ii) morphology differences in
colony (especially Penicillium sp.). Four different culture media, PDM, WM, Sucrose Yeast Medium
(SYM), and Czapek (Cza) were selected based on variations they offer with respect to carbon source
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and salt concentration. Additionally, the solid (“S”, agar plates, static) and liquid (“L”, 300 mL flasks,
shaking at 120 rpm) culture regimes were applied in order to enhance the chemical diversity of the
selected strains. The temperature was set to 22 ◦C in all samples. A simple coding system including the
strain number, growth medium, and culture regime was used to describe the extracts (e.g., 1PDM-L).
Table 1. The list of 26 F. vesiculosus-derived fungal isolates selected for OSMAC-based cultivation. Strain
I.D. numbers correspond to those used in strain collection in Table S1. Closest relative identification
showing high sequence similarity according to NCBI GenBank by BLAST and the original isolation
medium are displayed. * Strain could not be identified to genus level, but to a higher taxa (order) level.
Strain I.D. Epiphytic/Endophytic Fungus Closest Taxonomical Relative Sequence Similarity (%) Isolation Solid Medium
1 * Endophytic Pleosporales (order) 100 WM-S
11 Epiphytic Gibellulopsis sp. 100 GCM-S
12 Endophytic Acremonium sp. 99 WM-S
35 Endophytic Cadophora malorum 100 GYP-S
37 * Endophytic Hypocreales (order) 99 GYP-S
38 Endophytic Penicillium biourgeianum 100 WM-S
50 Endophytic Penicillium sp. 99 PDM-S
55 Endophytic Penicillium glabrum 100 PDM-S
56 Endophytic Penicillium sp. 100 WM-S
58 Endophytic Fusarium graminearum 96 WM-S
59 * Endophytic Glomerellales (order) 100 WM-S
61 Endophytic Penicillium brevicompactum 100 PDM-S
62 Endophytic Penicillium brevicompactum 100 PDM-S
67 Endophytic Gibellulopsis nigrescens 100 WM-S
68 Endophytic Penicillium sp. 100 WM-S
78 Endophytic Penicillium sp. 100 PDM-S
81 Endophytic Wallemia muriae 100 WM-S
82 Endophytic Emericellopsis sp. 99 WM-S
84 * Endophytic Hypocreales (order) 100 WM-S
86 Endophytic Emericellopsis terricola 99 PDM-S
87 * Endophytic Pleosporales (order) 99 WM-S
89 Endophytic Trichoderma sp. 100 WM-S
91 Endophytic Penicillium virgatum 100 GCM-S
96 Epiphytic Penicillium brevicompactum 100 GYP-S
104 Epiphytic Penicillium chrysogenum 100 WM-S
122 Endophytic Penicillium brevicompactum 100 GCM-S
The selected strains were cultured, and overall, under eight different conditions, for two weeks and
subsequently extracted with EtOAc to yield 208 crude extracts. These extracts were profiled for their
in vitro activity against six cancer cell lines (liver cancer cell line HepG2, colorectal adenocarcinoma
cell line HT29, malignant melanoma cell line A375, colon cancer cell line HCT116, lung carcinoma cell
line A549, human breast cancer line MDA-MB231) and for toxicity against the noncancerous human
keratinocyte cell line (HaCaT). Twenty-six samples that showed >90% growth inhibition at the initial
test concentration (200 µg/mL) against at least one cancer line were selected and further tested for
determination of their IC50 values. A threshold in anticancer activity (IC50 value ≤ 100 µg/mL against
at least one cancer line) was set as a second filter for further prioritization of the extracts. Hence,
10 endophytic strains complying with this criterium were selected and grown in four liquid and four
solid culture conditions to generate 80 extracts. Of these, only 16 extracts, all deriving from endophytic
strains (Table 2) inhibited at least one cancer cell line with an IC50 value of ≤ 100 µg/mL, whereas
the remaining 64 were inactive (IC50 > 100 µg/mL). Notably, 14 of the 16 fungal extracts that showed
anticancer activity (IC50 values 2–100 µg/mL) also inhibited the growth of HaCaT cells with similar
IC50 values, indicating a general toxicity. Only two crude extracts (1PDM-L and 58Cza-S) were active
against cancer cell lines (IC50 values 39–98 µg/mL) and possessed no toxicity against HaCaT cell lines
at 100 µg/mL concentration (Table 2). All sixteen extracts were selected for further studies.
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Table 2. List of 16 extracts deriving from 10 fungi with IC50 values ≤ 100 µg/mL against at least
one cancer line. Crude extracts were tested against six cancer cell lines (human liver cancer cell line
HepG2, human colorectal adenocarcinoma cell line HT29, human malignant melanoma cell line A375,
human colon cancer cell line HCT116, human lung carcinoma cell line A549 and human breast cancer
line MDA-MB231) and the non-cancerous human keratinocyte cell line HaCaT. Stand.: Standard for
positive control (doxorubicin). Strain I.D. corresponds to strain collection I.D. in Table S1.
Strain I.D. Taxonomic ID Medium & Regime
IC50 Value (µg/mL)
HepG2 HT29 A375 HCT116 A549 MDA-MB231 HaCaT
1 Pleosporales PDM-L 47 39 >100 >100 98 49 >100
35 Cadophora malorum PDM-L 15 50 4 6 16 35 5
37 Hypocreales PDM-L 11 27 5 7 18 7 8
50 Penicillium sp. PDM-L 11 100 8 8 15 7 9
PDM-S 6 16 29 8 10 2 2
Cza-S >100 >100 53 23 23 6 4
56 Penicillium sp. PDM-L 43 36 66 >100 42 35 69
Cza-L 100 100 63 >100 40 32 32
58 Fusariumgraminearum PDM-L 74 69 72 74 85 78 78
PDM-S 69 63 59 69 71 62 44
Cza-S 65 79 52 65 74 74 >100
59 Glomerellales PDM-S >100 >100 42 32 83 14 30
68 Penicillium sp. PDM-L 10 32 8 7 10 5 8
PDM-S 12 18 28 6 9 3 3
78 Penicillium sp. PDM-L 17 21 15 25 19 9 10
87 Pleosporales PDM-L 43 35 56 91 36 30 60
Stand. 14.9 3 0.13 10.6 31.4 15.2 10
The composition of the medium, as well as the culture regime, had a profound impact in bioactivity
and toxicity of the fungi (Table 2). For example, the crude extracts of strains 1 (order Pleosporales),
35 (Cadophora malorum), 37 (order Hypocreales), 78 (Penicillium sp.), and 87 (order Pleosporales),
inhibited the cancer cell lines only when fermented in liquid PDM medium (PDM-L). Similarly, strain
59 (order Glomerellales), cultivated only in PDM-S, displayed activity against four cancer cell lines,
particularly against MDA-MB231 cells (IC50 value 14 µg/mL, Table 2). The remaining strains were
either active in both liquid and solid cultures of one medium (e.g., Penicillium sp.—strain 68 in PDM),
or in multiple media and culture conditions, e.g., strain 56 (Penicillium sp.) and strain 58 (Fusarium
graminearum) (Table 2). In the case of strain 50 (Penicillium sp.), the extracts deriving from PDM-L and
PDM-S media showed higher potency in comparison to that deriving from the Cza-S medium.
2.3. Evaluation of the Chemical Diversity Using Molecular Network Approach
An UPLC-QToF-MS/MS based comparative untargeted metabolomics study (in positive
ionization mode) was carried out on those 10 initially selected strains (Figure S3). To ascertain
the impact of media and culture regime on the chemical profile, as well as to detect potentially
specific metabolites produced in the bioactive samples, 80 EtOAc extracts (10 strains grown in
8 culture conditions) were subjected to MN-based metabolomics analysis. The MS/MS data of
the extracts were analyzed using the publicly available Global Natural Products Social Molecular
Networking (GNPS) platform (https://gnps.ucsd.edu) [14] combined with both in-silico MS/MS
database (ISDB-UNPD) [16] and manual dereplication employing multiple databases (Dictionary
of Natural Products (DNP) [24], Scifinder [25], and Chemspider [26]). The global MN revealed
4782 nodes in total, of which 1700 were clustered in 255 chemical families, whereas the remaining
single nodes were considered as unique chemistries without link to others. Some nodes represent
adducts, thus, not all network nodes correspond to a single molecule. In the MN, 25 different chemical
families were annotated (Figures 4, 6 and 7 and Table S2), including various types of alkaloids,
polyketides, peptides, lipids, amino acid derivatives, dihydroxyanthraquinones, bile acids, polyenes,
and binaphthoquinones. Characteristic information for all annotated peak ions to known metabolites
(retention time, MS, MS/MS fragmentation, molecular formula, biological source and structure) is
displayed in Table S2. The global MN of fungal extracts based on culture regime and growth media
are shown in Figures 4A and 6A, respectively. The global MN-derived Euler and Venn diagrams
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(Figures 4B and 6B) display node (ion) distribution in different culture conditions, as discussed below.
The chemical composition of each individual strain is displayed in a separate MN (Figures S4–S23).Mar. Drugs 2019, 17, x 9 of 26 
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2.3.1. Impact of Culture Regime on Chemical Diversity
The effect of culture regime (liquid versus solid) was ascertained by comparing liquid and solid
culture groups from the MN (Figure 4A). The Euler diagram derived from MN (Figure 4B) pointed
out to clear differences in the chemical profile of the liquid and solid culture extracts. In total 4782
nodes (ions) were identified. The extracts deriving from the solid cultures (in total 3235 nodes) and
the liquid cultures (in total 2699 nodes) had only 1152 nodes in common, indicating <24% similarity
of total 4782 nodes (Figure 4B). Approximately, 32% of the total nodes (i.e., 1547 specific nodes) were
expressed exclusively in the liquid culture extracts, while 2083 nodes (≈43%) in the solid culture
extracts. The comparison of the liquid and solid culture-derived fungal extracts clearly points out a
differential chemistry. The observed metabolic differences suggest activation of different BGCs under
different culture regimes.
Annotation efforts of the chemical inventory of the extracts revealed only a few metabolites
to be common in both liquid and solid cultures, e.g., the aminolipid family (7–11) and aromatic
polyketide deoxyherquenone (25) (Figure 4A, Table S2) in both Cza-L and Cza-S media. Interestingly,
several metabolites were mapped to only one culture regime. For example, the cyclic depsipeptide
enniatin B1 (34) (Figure 4A and Figure S6) was detected only in liquid culture conditions. Importantly,
their production was dependent on the culture regime, but was not much affected by the growth media.
In addition to induction of different chemical families in individual culture regimes, we also observed
production of compounds in both culture regimes. A good example is the aromatic polyketide
family (21, 25, 29) that was detected in multiple extracts of strain 68 (Penicillium sp., Table S2).
Deoxyherquenone (25, m/z [M + H]+ 357.1544) was present in all liquid and solid culture extracts,
whereas its analogues atrovenetinone (29, m/z [M + H]+ 341.1123) and atrovenetin (21, m/z [M + H]+
343.1276) were exclusive to liquid culture regimes. As shown in Figure 5, with 22 nodes observed in
liquid culture-based extracts and 13 nodes in solid extracts of the strain 68, liquid culture conditions
clearly led to a higher chemical diversity for this molecular family, clearly demonstrating the impact of
the culture regime on variable chemical composition of the same strain.
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2.3.2. Impact of Cul ure Media on Chemical Diver i
Next, we investigated the influence of culture media on the extracts of 10 selected strains
(Figure 6A). The global MN-derived Venn diagram (Figure 6B) displays the distribution of altogether
4782 detected nodes. Notably, the Cza medium contained the highest number of nodes (2820),
whereas the lowest number of nodes (1615) was detected in the WM medium. The Venn diagram also
clearly indicated unique expression of significant numbers of nodes in one single culture medium.
For example, 1476 of all nodes (ions) were specifically mapped to the Cza medium, corresponding
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to 31% of in total 4782 nodes. Significantly lower levels of nodes that were found to be exclusive to
other media, i.e., 487 (PDM), 441 (SYM), and 370 (WM) (Figure 6B). These results confirmed that the
chemical composition and other characteristics (e.g., selected carbon resource) of the growth media had
a significant effect on the chemical machinery of the fungi derived from F. vesiculosus. The inspection
of Table 2 indicated that most of the bioactive extracts that inhibited the growth of the cancer cell lines
derived from the liquid PDM medium. Three extracts obtained from the Czapek culture also showed
activities with lower potency.
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The global MN of the crude extracts deriving from different media (Figure 6A) indicated variations
in chemical diversity of the extracts. The annotated natural product clusters included e.g., fumagillin
(26) type meroterpenoid mycotoxins, which were only expressed by strain 35 (Cadophora malorum) in
SYM-L (Figure 6A, Figure S6 and Table S2), while the small binaphthoquinone family represented only
by xanthoepocin (19) and bisdehydroxanthomegnin (20) that was exclusively mapped to PDM-L extract
of strain 59 (order Glomerellales) (Figure 6A, Figure S16 and Table S2). Another striking example
was the aminolipid family (7–11) produced by the same strain 59. This very large molecular cluster
was expressed in both liquid and solid Cza media, with 52 of total 71 analogues with m/z ranging
from 300 to 1300 Da exclusively mapped to the Cza medium (Table S2, Figure S24). The identification
of this rare lipid family was based on the database search in GNPS, with a high spectral similarity
score (>0.7) to our experimental MS/MS fragmentation pattern. The inspection of Figures 4 and 6,
the Supplementary Figures S4–S23 and Table S2 shows that, with the exception of the amide alkaloid
pseurotin A (6) and the polyketide deoxyherquenone (25), all annotated chemical families/compounds
are produced by one single strain often in one or more growth media. In most cases, both culture
regime and culture media had an effect on chemical production, in which 15 of the total 36 known
metabolites were exclusively annotated in one single culture medium under one single culture regime
(Table S2). This was exemplified by the amino acid derivative acetylcarnitine (1, SYM-S) (Figure S5),
the tetrahydrofuranone polyketide griseofulvin (15, WM-L) (Figure S18), and the indole diterpenoid
penitrem B (30, SYM-S) (Figure S19). Despite the use of an integrated and detailed metabolomics
approach, we were able to annotate only a few nodes to known compounds. This may suggest potential
novelty of the remaining compounds.
2.3.3. Bioactivity Mapping
As a last step, we mapped the bioactivity data (IC50 values) of altogether 80 extracts over the MN
and searched for a link between spectral molecular networks and their anticancer activity (or toxicity).
To this end, we classified the fungal extracts into three groups based on their anticancer activity (IC50
values), assigned them a specific color tag, and applied this color mapping to all nodes to establish a
visible MN (Figure 7A). Thus i) 64 extracts that did not kill any cancer cell line in preliminary testing
(IC50 > 100 µg/mL, see Section 2.2) were regarded as ‘inactive’ (tagged in grey), ii) 14 extracts that
exhibited anticancer activity towards at least one cancer cell line and general toxicity to HaCaT cells
with IC50 values < 100 µg/mL were treated as ‘toxic’ (tagged in red) and iii) 2 crude extracts (1PDM-L
and 58Cza-S) that were devoid of toxicity against HaCaT cells (IC50 > 100 µg/mL) and killed at least
one cancer cell line (IC50 < 100 µg/mL) were regarded as ‘bioactive’ (tagged in blue) (Figure 7A).
Then, we explored the networks and compared the chemical composition of all three classes with
different color mapping to all nodes in the MN. The rationale behind it is that if certain clusters/nodes
are uniquely present in an extract, these compounds may possibly be responsible for the observed
bioactivity and this extract(s) can be prioritized for further bioactivity-guided isolation studies.
As shown in the Euler diagram (Figure 7B), altogether 4452 nodes were detected in the inactive
extracts, 2207 nodes in the toxic extracts, while the two bioactive extracts collectively comprised
175 nodes. Respectively, 2499 and 295 nodes were exclusive to the inactive and the toxic extracts.
The bioactive extracts had only eight nodes that were specifically produced in them, but shared 27
nodes with the toxic and 68 with inactive extracts. Seventy-two nodes were common to all extracts.
The combination of massive MN with activity mapping allowed an easy visual inspection of the
networks and their inhibitory activity against cancerous and non-cancerous cell lines. As shown in
Figure 7A, the MN revealed eight fully exclusive (completely blue) ions for bioactive extracts 1PDM-L
and 58Cza-S, five of which belonging to 1PDM-L and three of which belonging to 58Cza-S. Only one
of these nodes identified from 1PDM-L (m/z [M + H]+ 428.2081, C25H34NO5) was embedded in a large
molecular cluster containing 38 nodes (Figure 7A and Figure S25). The remaining seven were single
nodes (single compound-single molecular family, Figure 7A), four of which being exclusive to 1PDM-L
(m/z [M + Na]+ 452.2278 (C25H35NO5Na), m/z [M + H]+ 469.2242 (C27H33O7), m/z [M + H]+ 463.2679
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(C26H39O7), m/z [M + H]+ 939.6554 (C55H91N2O10)) and 3 nodes being exclusive to 58Cza-S (m/z
[M + H]+ 232.1525 (C11H22NO4), m/z [M + H]+ 681.3819 (C31H57N2O14), and m/z [M + H]+ 685.3978
(C32H61O15)). None of these eight nodes found a match to any known compound in databases, hence
represent potentially new compounds that may be responsible or contributing to the bioactivity of
these extracts. On the other hand, the blue nodes were also common to a number of networks that
were toxic. This may suggest that the observed toxicity and anticancer activity is dependent on their
final concentration in the extract and the chemical structure of the individual compounds and/or their
molecular clusters. The fully toxic ions (fully red nodes) were represented by small networks and a
number of single nodes. However, similar to bioactive samples, the toxicity was also embedded in
many inactive (grey) networks. As expected, there were many fully inactive molecular clusters, but a
large number of clusters included toxic and/or bioactive nodes, again pointing to general phenomenon
of toxicity associated with anticancer activity.Mar. Drugs 2019, 17, x 13 of 26 
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Figure 7. (A) Bioactivity (IC50 values) appe to global MN of the extracts of 10 fungal strains
(80 extracts). See Table S2 for annotated molecules. Red node: Ions detected in toxic samples
(IC50 < 100 µg/mL towards both cancerous and non-cancerous HaCaT cell lines). Grey node: Ions
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in brackets.
3. Discussion
3.1. Fungal Isolation
Only a few studies have investigated endophytic fungi associated with the seaweed genus
Fucus and their metabolites with antioxidant and antibiotic activities [6,7]. In this study, we isolated
fungal assemblages present on the surface and in the inner tissues of the Baltic Sea F. vesiculosus.
Isolation media (mostly favoring the growth of Ascomycetes) used herein were similar to those used
for obtaining endophytic fungi from the North Se F. serratus [1,27]. In accordance with previous
studies, our isola s were also domi ated by Penicillium sp. that are common in macroalgae [28].
The abundance of Pe icillium sp. (39 isolat s) in our study was even higher than that (14 isolates)
observed in the previous study [1]. Reportedly, the abundance of Penicillium sp. in macroalgae is
negatively correlated with water temperature [29]. Low water temperatures (8.3 ◦C) during our
sampling campaign may provide a possible explanation for the higher abundance of Penicillium sp.
Vice versa, the abundance of another very common genus in macroalgae, Aspergillus, is reportedly
positively correlated with increasing temperatures [29], which may underlie the absence of Aspergillus
sp. in our study. Zuccaro et al. [1] isolated only a few (5 isolates) Aspergillus sp. during their study
on F. serratus for a full calendar year, suggesting an overall low abundance of the genus Aspergillus in
Fucus species.
In addition, we identified four genera Acremonium, Gibellulopsis, Trichoderma, and Emericellopsis
(Figure 3A) from the Baltic F. vesiculosus. Since they are absent in the sediment or seawater samples,
they can be regarded as specific to the seaweed. These genera have also been isolated from the
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North Sea F. serratus samples [1]. A Cadophora sp. has previously been reported from the green alga
Enteromorpha sp. [30], but not from any brown algae before. In the present study, we identified an
endophytic Wallemia sp. This fungal genus is generally considered as xerophilic (adapted to dry
conditions or high salinity) [31], and has previously been obtained from air, soil, dried food, and salt.
To our knowledge, this is the first report of this genus being associated with a marine alga. The seawater
control sample yielded a Candida sp., which is commonly found in seawater [32]. Finally, we isolated
three fungal strains, Cladosporium sp., Phoma sp. and Stereum sp., that were exclusive to sediment
surrounding F. vesiculosus (Figure 3A). Cladosporium and Phoma species are very common molds in
sediment samples [33]. Stereum species belong to mycobiota of trees and known for wood-destroying
and carbon recycling properties of arid forest ecosystems [34], but has never been isolated from a
marine sediment before.
Interestingly, two known plant pathogens i.e., Cadophora malorum and Fusarium graminearum were
also isolated from the inner tissues of F. vesiculosus. The presence of potential phytopathogens in
macroalgae has already been described [1,27]. Those endophytes live in a healthy host resuming a
saprophytic growth only during senescence of the hosts [1]. While their ecological role in F. vesiculosus
remains elusive, these fungal genera that produce bioactive compounds, such as the hydroxylated
sclerosporin derivatives reported from Cadophora malorum [30], may be involved in the well-being of
the marine algae.
It is widely accepted that Fucus sp. employs various mechanisms to control their surface biofilm
and microbiota. This includes mechanical means, i.e., cuticle shedding [35], production of reactive
oxygen species (ROS) [36], and the release of secondary metabolites, such as the carotenoid fucoxanthin,
onto the algal surface [37,38]. Such regulatory mechanisms of epiphytic control may underlie the
4-fold lower abundance of epiphytic fungi (11 isolates) compared to endophytic fungi (44 isolates).
The diversity of epiphytic fungi was also poor and only three genera, Gibellulopsis (1 isolate), Phoma
(1 isolate), and Penicillium (9 isolates) represented the cultivable epiphytic fungal community. Notably,
none of the epiphytic fungi showed growth inhibitory activity against cancer cell lines in initial
screenings, and hence, were not prioritized for in-depth metabolomics and IC50 determinations.
3.2. Evaluation of Chemical Diversity Under Different Culture Conditions
OSMAC is regarded as an essential method for activating silent BGCs to enhance the chemical
diversity of microorganisms [39]. Here, we applied for the first time an OSMAC-based cultivation
approach to F. vesiculosus-derived fungal strains, 10 of which inhibited the growth of multiple cancer
cell lines in vitro. The UPLC-HRMS/MS-based untargeted metabolomics study by employing MN on
16 fungal extracts deriving from 10 selected fungal isolates revealed an enhanced chemical diversity,
as shown in their respective MNs (Figures S4–S23). As discussed below, MNs provided opportunities
to identify known compounds/molecular families and putatively new molecular families and to
assess differences due to changes in the culture regime and the growth media. Overall, 36 metabolites
belonging to 25 clusters were putatively identified, spanning from simple amino acids, fatty acid
derivatives (including sphingolipids, aminolipids, aminoglycolipids), various types of alkaloids and
polyketides, terpenoids, meroterpenoids, and steroids.
In this study, liquid and solid culture extracts only shared 24% nodes and more than 30% nodes
were produced only under one single culture regime (Figure 4B). In-depth MN studies revealed
that 16 putatively identified metabolites were exclusive to liquid culture regimes and 11 to solid
regimes (Table S2). A similar MN-based metabolomics study conducted on marine bacterial extracts
confirmed the strong impact of the culture regime on chemical diversity in which only 7% of the
nodes were shared [17]. The differences in chemical production under different culture conditions
may stem from changes in physical parameters, e.g., shaking that increases the availability of oxygen.
As reviewed by Papagianni et al. [40], the production of metabolites in different morphological and
physiological conditions is unique for each fungus. In this study, we applied shaking (120 rpm)
to the liquid cultures, while the solid cultures were grown statically. Previous research on fungal
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antibiotics showed that fungi formed mycelial mat under static conditions and dispersed mycelia under
shaking condition. The chemical production was affected by different mycelial growth conditions [41].
Our results confirmed differential biosynthesis of various types of metabolites in liquid (1547 specific
nodes) and solid (2083 specific nodes) cultures (Figure 4B). Another factor affecting the fungal growth
and metabolome is the availability of oxygen. The lack of oxygen in solid media has been shown
to lead to impairment of the fungal growth and decreased production of fungal metabolites [42].
Conversely, shaking (in liquid conditions) facilitates aeration and the uptake of oxygen, thereby
promoting fungal growth and potential accumulation of bioactive metabolites. While a lower number
of nodes were expressed in the liquid culture extracts (i.e., 1547 specific nodes versus 2083 nodes in
the solid extracts, 32 versus 43%, respectively) the liquid culture regime appeared more favorable for
the expression of bioactive/cytotoxic metabolites than the solid regime. Many fungal mycotoxins,
such as the enniatin type cyclic depsipeptides (31, 34, 36) (produced by strain 35), fumagillins (26),
and the diterpene glycoside virescenoside E (35) (produced by strain 1), were exclusively expressed
in liquid culture extracts. Ten of the total 16 active extracts with activity against cancer cell lines
derive from liquid growth media and only six strains showed bioactivity against cancer cell lines when
grown under solid static condition (Table 2). Expression of specific fungal metabolites under shaking
has previously been observed by Guo and co-workers [43] where the switch of the culture condition
of a Penicillium sp. from static to shaking led to the biosynthesis of five new nitrogen-containing
sorbicillinoids [44]. Analogously, we detected 16 specific metabolites in liquid culture extracts,
exemplified by the antifungal polyketide griseofulvin (Figure S18).
The culture media also played a significant role in the chemical diversity of the F. vesiculosus
associated fungi. The Venn diagram (Figure 6B) showed that Cza medium provided not only chemically
the most diverse extracts with the highest numbers of nodes (2820), but also the highest number of
nodes (1476) exclusively produced in this medium. MN annotated specific metabolites that were
produced in a single medium i.e., Cza (4, 8, 9, 10, 11, 32), PDM (5, 19, 20), SYM (1, 14, 26, 28, 30, 33),
and WM (2, 12, 15) (Table S2). Annotation of metabolites that can be mapped exclusively to a certain
medium suggests activation of silent BGCs due to varying culture parameters. This metabolism shift
may be due to different nutrients used in this study, e.g., carbon, trace elements and salt. For example,
Cza is the only medium containing sucrose (as carbon source) and trace metals (e.g., Mg2+) at the
same time. The influence of carbon source on fungal metabolism is well known. For example only
sucrose has stimulated the production of antibiotic metabolite bikaverin in Fusarium fujikuroi [45].
In the current work, the linear aminolipid family (7–11) produced by strain 59 (Table S2, Figure S24)
was exclusively detected in the sucrose-containing medium Cza. Chatzifragkou and co-workers (2010)
showed that carbon source affects the lipid production in fungi and the highest oleic acid concentration
was obtained when a sucrose-based medium was used [46]. Additional research showed several
enzymes that are involved in the regulation of lipid synthesis, e.g., ATP citrate lyase, were dependent
of Mg2+ for their activities [47,48]. The use of Cza as medium for culturing the strain 59 (order
Glomerellales) resulted in the highest number of metabolites (2820 nodes) and highest percentage
(31%) of compounds unique to this medium, as a response to the presence of specific nutrients, e.g.,
trace elements and sucrose.
PDM was the only medium containing a mixed carbon source, i.e., the polymer starch and the
monomer dextrose. The anti-inflammatory metabolite dihydroxyanthraquinone questinol (5) [49] was
previously isolated from the marine derived fungus Eurotium amstelodami incubated in a starch-based
SWS medium. The strain 50 (Penicillium sp.) exclusively produced this compound in the starch
containing medium PDM (Figure S10), pointing out the importance of the polymeric starch as carbon
resource. The total number of nodes in PDM extracts was 1628, of which 487 were exclusive to this
medium. Only a few nodes mapped to PDM were annotated to known metabolites, this suggests that
fungal strains are able to produce a rich number of putative new natural products when cultured in a
PDM medium. Importantly, most of the extracts with growth inhibitory activity against cancerous
(and non-cancerous) cell lines were grown in solid or liquid PDM (Table 2). Thus, all 10 strains showed
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low IC50 values (<100 µg/mL) against cancer cell lines in PDM (six fungi only in PDM-L, one fungus
only in PDM-S, and three strains—50, 58, and 68 in both PDM-L and PDM-S) (Table 2).
The third medium, SYM, contained sucrose and yeast extract as nutrient provider. These two
components appeared suitable for production of mycotoxins. There were altogether 1990 nodes
detected in SYM extracts, with 441 nodes being exclusive. Previous research on Aspergillus flavus
showed that the absence of yeast extract led to silencing of mycotoxin production in fungi [44]. In the
present study, several known fungal mycotoxins families, such as the small cluster of fumagillin family
(26 produced by strain 35, Figure S6) and a very large cluster of penitrem family (30, produced by
strain 68, Figure S19) were assigned to be exclusive to SYM by analysis of the MN.
The last medium, WM contains high concentrations of salt (NaCl 30 g/L). As shown in Figure 6B,
1615 nodes in total were observed in WM extracts, 370 of these being specific to this medium. One such
compound is griseofulvin (15), a chlorinated tetrahydrofuranone polyketide produced by the strain 68
(Figure S18). Griseofulvin was only annotated from the 68WM-L extract, potentially as a response to
high Cl+ concentration. Glucose is an excellent carbon resource for fungal growth, however, it may
repress the transcription of biosynthetic genes, such as pcbAB, pcbC, and penDE in Penicillium sp. [50]
resulting in a poor metabolite diversity. Finally the presence of salts may impair the growth of some
fungi, leading to a poor chemical composition. This could be another factor contributing to the low
chemical diversity and lack of bioactivity of the crude extracts derived from salt-containing media,
SYM and WM.
It is important to mention that the chemical production of strains was not only affected by the
culture regime but also by the culture media. The most striking example is represented by the indole
diterpenoid penitrem B (30). A previous study showed that penitrems were only produced under
static conditions and enhanced production occurs upon addition of sucrose and yeast extract into
medium [51]. Accordingly, we detected the penitrem B (30), exclusively, in solid SYM culture of strain
68 (Penicillium sp.) (Figure S19). This indicates that both culture regime and culture media strongly
affect fungal chemical diversity of the fungi. Our research that employed detailed metabolomics
by MN and bioactivity testing underlines the complexity of the media effect on fungal metabolism
and bioactivity as a result of it. Overall, the OSMAC approach applied here suggests PDM-L as the
best culture condition for a high chemical diversity coupled with cancer growth inhibitory activity
in F. vesiculosus-derived fungi. While the Cza medium provided the highest chemical diversity and
exclusiveness in metabolites, only a few extracts deriving from this medium showed generally low
anticancer activity associated with toxicity. It is very likely that these extracts/induced compounds
have other biological activities, which warrants further screenings in future.
3.3. Bioactivity
Based on the proven anticancer potential of algal-derived fungi [9], we focused on
the assessment of the anticancer activity and general toxicity of F. vesiculosus derived fungi.
An IC50 value ≤ 100 µg/mL was set to define the bioactivity of the crude extracts. The changes
in the fungal metabolism due to composition of the culture medium and/or the culture regime played
a very important role in the observed bioactivity of the crude extracts. Hence, out of 80 extracts,
only 16 fulfilled the IC50 value criterium (≤100 µg/mL). Some extracts showed significant variations
in their potency against different cancer cells. For example, 50Cza-S was inactive against HepG2 and
HT29 cells, but showed good IC50 values against other cancerous cell lines, in particular towards
MDA-MB231. However, the majority of the extracts suffered from the lack of selectivity, as their
anticancer activity was often comparable to their general toxicity towards non-cancerous HaCaT cells.
As exemplified by doxorubicin, the standard drug used as a positive control herein (Table 2), toxicity
is a well-known general side effect of anticancer drugs. Only two extracts 1PDM-L and 58Cza-S
lacked toxicity at the highest test concentrations (IC50 >100 µg/mL), but their anticancer effect was
also moderate.
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Our dereplication study indicated the presence of some known chemical families, including
mycotoxins, in the fungal extracts. Indeed, we annotated 11 individual mycotoxins belonging to
eight chemical families that were previously reported as fungal mycotoxins. These include the
amide alkaloid pseurotin A (6), polyketide griseofulvin (15), polyene fusarin C (16), bis-anhydrides
rubratoxins A (18) and B (17), meroterpenoid fumagillin (26), indole diterpenoid penitrem B (30), cyclic
depsipeptides enniatins B, B1, and A (31, 34, 36), and the diterpene glycoside virescenoside E (35).
Several mycotoxins with demonstrated anticancer and/or cytotoxic activities (the existing literature
mostly measured their anticancer activity without assessing their toxicity) were detected, and their
bioactivity was often dependent on the culture conditions. Rubratoxins are common mycotoxins of
Penicillium sp. [52,53] with specific protein phosphatase A2 inhibitory and anticancer/antimetastasis
activities [54]. Rubratoxins A (18, m/z [M + H]+ 521.1890) and B (17, m/z [M + H]+ 519.1832) were only
annotated in the toxic PDM-L and Cza-L extracts of strain 50 (Penicillium sp.) (Table S2, Figure S10).
This molecular cluster contained four additional unannotated nodes (m/z [M + H]+ 598.1872, 577.1812,
767.2503, and 768.2531), which were only induced in this strain when incubated in PDM-L medium
(Figure S10). These results suggest that culture conditions enhance the expression of fungal BGCs to
induce biosynthesis of certain molecular families with new, potentially bioactive congeners. Enniatin
type mycotoxins (31, 34, 36) with known anticancer properties [55] were also abundant in the toxic
PDM-L extract of strain 35 (Cadophora malorum) (Figure S6). Other mycotoxin families, e.g., fumagillins
(26) and pseurotins (6) with known anticancer/cytotoxic activity were expressed in 35SYM-L and
78WM-S, which lacked anticancer activity. The bioactivity mapping further proved this, as many
toxic/anticancer mycotoxin clusters (fumagillins, pseurotins, penitrems, etc) were detected in grey
colored networks belonging to inactive extracts. This may stem from their low concentrations in the
extract and/or overall chemical composition of these extracts.
MN has found successful applications in drug discovery, in the form of bioactivity mapping
and bioactivity-based MN for prioritization of extracts and targeted isolation of bioactive natural
products [17,56]. In this study, we applied OSMAC approach with varied growth media and culture
regime and mapped its results on MN for assessing both bioactivity and molecular profile of the
extracts. The crude extracts were classified into three different groups based on their IC50 values (≤100
µg/mL) and toxicity to HaCaT. The layout assigned color tags to each group, which allowed i) rapid
and efficient visualization and analysis of molecular clusters, and ii) analysis of whether these specific
cluster of nodes were restricted to certain strain, growth medium, or culture regime. By using this
visible network, we attempted to detect unique metabolites produced in bioactive samples. Toxicity
is the main limitation in anticancer drug discovery. Accordingly, 14 extracts showed significant
toxicity whereas the extracts derived from the strain 1 (order Pleosporales) in PDM-L and strain 58
(Fusarium graminearum) in Cza-S media showed moderate anticancer potential with no toxicity at
100 µg/mL. MN-based bioactivity mapping identified 8 unannotated nodes to be exclusively present
in these two extracts, indicating their potential impact in the observed activity. Then, we attempted
to annotate known metabolites in these bioactive extracts. The only secondary metabolite we could
annotate in the 1PDM-L extract was the diterpene glycoside virescenoside E (35, Figure S4), which is
regarded as a fungal mycotoxin [57]. This compound belonged to a small, four-membered molecular
cluster, however, none of the compounds in this cluster were unique to 1PDM-L, so their significant
contribution to bioactivity is unclear. We were unable to dereplicate any nodes in the other selectively
active extract 58Cza-S. However, we found one significant cluster in this crude extract (Figure S26) that
was distributed in all three groups of extracts (inactive, toxic and bioactive). Dereplication efforts on
three nodes specific to 58Cza-S, i.e., m/z [M + H]+ 401.3221, [M + H]+ 403.3355, [M + H]+ 419.3300, and
their MS spectral fragments did not match any known compounds in the databases used. These three
compounds are closely related and may potentially represent new metabolites.
Besides the mycotoxins described above, a few other dereplicated metabolites reportedly exerting
anticancer activity were mapped to toxic or inactive extracts. For example, ergosterol (28), the major
steroidal constituent of fungal membranes with inhibitory activity against several cancer cell lines [58]
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was detected in the inactive 35SYM-L extract (Figure S6). Phomopsidin (33) is a polyketide that
interacts with microtubules [59]. This compound that was embedded in a small molecular family was
annotated and originated from the inactive sample 87SYM-L (Figure S22). We also observed various
chemical families without reported anticancer activity. This was exemplified by the sesterterpenoid
citreohybridonol (13, m/z 501.2903, [M + H]+) identified from strain 68 (Penicillium sp.) grown in
several solid-liquid media, however only the 68PDM-S showed activity associated with strong toxicity
(Table S2, Figure S18).
In conclusion, we have isolated and identified, for the first time, a diverse cultivable fungal
community associated with the Baltic Sea F. vesiculosus. The use of an OSMAC approach combined
with efficient and modern tools such as MN coupled with bioactivity mapping, enabled the
identification of optimal culture conditions and clear visual comparison of the chemical diversity and
bioactivity of the extracts. Based on this important information, strain 1 (order Pleosporales) was
prioritized for large-scale fermentation to be followed by purification and structure elucidation of its
bioactive components.
4. Materials and Methods
4.1. General Experimental Procedures
EtOAc (used for fungal extraction) was purchased from VWR International GmbH, Hannover,
Germany. UPLC grade methanol, acetonitrile and water used for UPLC/MS analysis were purchased
from BiosolveChimie, Dieuze, France. Formic acid (UPLC/MS optigrade) was obtained from LGC
Standards Promochem©, Wesel, Germany. UPLC-QToF-MS/MS analyses were carried out on an
ACQUITY UPLC I-Class System coupled to the Xevo G2-XS QToF Mass Spectrometer (Waters®,
Milford, MA, USA). Czapek broth, yeast extracts and malt extracts were purchased from BD Bioscience,
Sparks, NE, USA. Agar was purchased from Applichem, Darmstadt, Germany. Peptone from
soymeal and glucose were purchased from Merck, Darmstadt, Germany. Potato extract was from
Sigma-Aldrich, Schnelldorf, Germany. Sucrose was purchased from Handelsmarken, Offenburg,
Germany. Casein hydrolysate was purchased from Carl Roth, Karlsruhe, Germany.
4.2. Sampling and Isolation of Fungi
All fungi were isolated and identified from F. vesiculosus (Class: Phaeophyceae, Order: Fucales,
Family: Fucaceae) specimens collected in Falckenstein Beach (54◦23′22.6” N, 10◦11′26.4” E), Kiel Fjord,
Baltic Sea, Germany in December 2015 (pH 7, water temperature 8.3 ◦C). For isolation of fungal strains,
four solid media were used: modified Wickerham medium (WM: NaCl 30 g, glucose 10 g, peptone
from soymeal 5 g, yeast extract 3 g, malt extract 3 g, agar 15 g for 1 L), Glucose Yeast Peptone medium
(GPY: glucose monohydrate 1 g, peptone 0.5 g, yeast extract 0.1 g, sodium chloride 15 g, agar 15 g for
1 L; pH 7.2), Potato Dextrose medium (PDM: Potato extract 4 g, dextrose 20 g, agar 15 g for 1 L; pH 5.6),
and Glucose Casein medium (GCM: casein hydrolysate 2.5 g, glucose 40 g, MgSO4 0.1 g, KH2PO4 1.8 g,
agar 15 g for 1 L pH 6.8) [60,61]. All media were enriched with 100µg/mL streptomycin and 100 µg/mL
of penicillin to suppress bacterial growth. Before plating, the macroalgal specimens were washed
three times with sterilized saline solution (0.9 g/L NaCl). Epibionts were obtained from the surface of
conceptacles, stipe, and holdfast regions by sterile cotton swabs. For isolation of endophytic fungi, the
algal surface was disinfected by 40% ethanol and 1% sodium hypochlorite for 1 min [62]. Algal tissues
from conceptacles, stipe and holdfast regions were cut into approximately 4 mm × 1 mm fragments.
Each fragment was put into a 2 mL innuSPEED lysis tube type S containing 0.4–0.6 mm ceramic beads
(Analytik Jena, Jena, Germany) and 600 µL of sterilized 0.9% saline. Samples were homogenized for
about 2 min at 15 Hertz (15/s) with the RetschMM200 mixer mill (RetschGmbHH, Haan, Germany)
to release the endophytes from tissue to saline. Low speed mixing was pursued in order to prevent
destruction of the endophytic fungal cells. After homogenization, two dilutions of mixture (containing
endophyte fungi and saline), namely 10−1 and 10−2 were prepared. An aliquot (100 µL) of the dilutions
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as well as of the undiluted sample were inoculated on the above-mentioned 4 agar media and spread
evenly using drigalski spatula. Surface sterilized tissues of F. vesiculosus was swabbed again and
incubated on the same 4 solid media to evaluate the effects of surface sterilization. Samples were
incubated for 14 days at 22 ◦C and checked for fungal growth twice per week. Fungal colonies were
transferred to new plates and incubated until pure cultures were obtained. For cryopreservation,
the pure fungal strains were transferred to cryobank tubes (MAST Diagnostica, Reinfeld, Germany)
and stored at −100 ◦C following the manufacturer’s instructions.
4.3. Identification of Fungal Strains
Fungal communities were identified based on the nuclear ribosomal internal transcribed spacer
(ITS) region containing the ITS1 and ITS2 regions, which frame the 5.8S rRNA gene. The ITS region is
generally accepted as a universal phylogenetic marker for fungi [63]. DNA extraction was performed
according to the protocol published previously [64]. PCR amplification was performed using primers
ITS1F and ITS4R, in a total reaction volume of 25 µL, consisting of 1 µL of template DNA, 1 µL of
each primer (concentration: 10 µM), 12.5 µL Dream Taq Master mix (ThermoFisherScientific, Schwerte,
Germany), and 9.5 µL DNA free water (ThermoFisher Scientific, Schwerte, Germany). DNA free water
was used as negative control for PCR. The following protocol was used in a Biometra T1 thermocycler
for amplification: initial denaturation for 85 s at 94 ◦C, followed by 30 cycles of denaturation of DNA at
94 ◦C for 35 s, primer annealing at 55 ◦C for 55 s, and elongation for 3 min at 72 ◦C. A final elongation
step for 10 min at 72 ◦C completed the PCR. The correct length of PCR products was checked by gel
electrophoresis on a 1% agarose gel run for 20 min at a voltage of 120 V in 1× TBE buffer, taking 100 bp
plus DNA ladder (Thermo Scientific™ GeneRuler™, Sunnyvale, CA, USA) length standard. PCR
products were submitted for Sanger sequencing to the Institute of Clinical Molecular Biology (IKMB)
at Kiel University applying the same primers as used for PCR. Obtained sequences were checked
for quality and trimmed using Chromas Pro (Technelysium Pty Ltd., South Brisbane, Australia).
Sequences were then compared to the NCBI Genbank (https://www.ncbi.nlm.nih.gov/genbank/)
using the Nucleotide BLAST function. Sequences were stored at GenBank and the accession numbers
are displayed in Table S1. An MDS plot showing differences between samples (seawater, sediment,
Fucus epiphytic, Fucus endophytic) was generated using the statistical software PAST based on a
presence/absence matrix of identified fungal genera in 87 identified isolates [65].
4.4. OSMAC-Based Cultivation of Fungi
The fungi were incubated in four different media, which were chosen based on variations in
their carbon and nitrogen sources and salt concentration: The modified Wickerham medium (WM),
Czapek medium (Cza: sucrose 30 g, KH2PO4 1 g, MgSO4 0.5 g, KCl 0.5 g, Fe2(SO4)3 0.01 g for 1 L;
pH 7.3), Potato Dextrose medium (PDM), and Sucrose Yeast medium (SYM: sucrose 20 g, yeast extract
10 g, NaCl 10 g for 1L; pH 5.2) [61]. These media were selected in order to provide different nutrient
regimes to activate biosynthetic gene clusters [12]. Each fungal strain was incubated in all four media
by applying two different culture regimes (solid and liquid). The solid culturing contained 15 g/L agar
as solidifying agent and liquid media (100 mL medium in 300 mL Erlenmeyer flasks). Solid cultures
were incubated at 22 ◦C for 14 days in the dark under static conditions. The liquid cultures were
incubated on an orbital shaker (VKS-75 control, Edmund Bühler, Hechingen, Germany) agitating at
120 rpm at 22 ◦C for 14 days in the dark.
4.5. Extraction
For extraction of the liquid cultures, 100 mL of culture broth were mixed with the same volume
of EtOAc by means of an ultra-turrax (Miccra, Mülheim, Germany) at 19,000 rpm. The mycelia
were filtered by folded filter cellulose membrane type 113P (100% cellulose membrane 210 mm,
Carl Roth, Karlsruhe, Germany). The filtrate was collected into a glass separatory funnel and left
for phase separation. The lower (water) phase was discarded. 40 mL of Milli-Q water (Arium®
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Water Purification Systems, Sartorius, Germany) was added to the organic phase to remove salts
and water-soluble compounds. After phase separation, the water phase was discarded, and the
EtOAc phase was transferred into 40 mL glass tubes. The extracts were evaporated to dryness by
a Speed-Vac concentrator (RVC2-33, Martin Christ Gefriertrocknungsanlagen, Osterode am Harz,
Germany). The dissolved crude extracts were re-dissolved in 2.5 mL MeOH and transferred into 4 mL
pre-weighted HPLC vials (amber glass, VWR, International GmbH, Hannover, Germany). For chemical
analysis, 0.1 mg/mL of extract was prepared in an ULC/MS grade MeOH and transferred into
1.5 mL vials (amber glass, VWR, International GmbH, Hannover, Germany). The dissolved extracts
were filtered through 0.20 µm PTFE syringe filter (Carl Roth, Karlsruhe, Germany) before injection.
Solid fungal cultures were sliced into small pieces (approximately 1 cm2) with a flat spatula and
transferred into a 250 mL glass flask and homogenized with 100 mL EtOAc by means of an ultra-turrax
at 19,000 rpm for 30 s. The extraction process for solid cultures followed the same steps as applied
for liquid cultures. The media blanks were prepared by extracting liquid and solid media using the
same protocol.
4.6. Chemical Analysis
4.6.1. UPLC-QToF-MS/MS Analysis
The extracts were prepared at final concentration of 0.1 mg/mL and injected (2 µL) into an Acquity
UPLC HSS T3 column (High Strength Silica C18, 1.8 µm, 2.1 × 100 mm, Waters®) operating at 40 ◦C.
A mobile phase system (A: 0.1% formic acid in 99.9% ULC/MS grade water and B: 0.1% formic acid
in 99.9% acetonitrile) was pumped at a flow rate of 0.6 mL/min using the following linear gradient:
initial, 99% A–1% B; 0–11.5 min, 0% A–100% B; 11.5–12.5 min 0% A–100% B, and finally a column
reconditioning phase until 15 min. The total run time was 15 min. MS and MS/MS spectra, in positive
mode, were recorded during the UPLC run with the following conditions: capillary voltage: 0.8 kV,
sample cone voltage: 40.0 V, source temperature: 150 ◦C, desolvation temperature: 550 ◦C, cone gas
flow: 50 L/h and desolvation gas flow: 1200 L/h. A scan range was performed from 50 to 1600 Da,
MS2 fragmentation was achieved with ramp collision energy (CE): Low CE from 6–60 eV and a high
CE of 9–80 eV. The solvent (MeOH) and non-inoculated blank media were used as controls. MS and
MS2 data were acquired and analyzed with MassLynx® software (Waters®, V4.1, Waters, Milford,
MA, USA).
4.6.2. Molecular Network and Data Analysis
All MS/MS data were converted from files (.raw) to mzXML file format using the ProteoWizard
tool MSConvert (version 3.0.10051, Vanderbilt University, Nashville, TE, USA) [66]. The data were
uploaded to GNPS server (gnps.ucsd.edu) [14] by using FileZilla (https://filezilla-project.org/) [67].
All mzXML data were analyzed using the molecular networking workflow. A molecular network
was created using the online workflow at GNPS. The data was filtered by removing all MS/MS peaks
within +/− 17 Da of the precursor m/z. The data were then clustered with MS-Cluster with a parent
mass tolerance of 0.1 Da and a MS/MS fragment ion tolerance of 0.1 Da to create consensus spectra.
Further, consensus spectra that contained less than 2 spectra were discarded. A network was then
created where the edges were filtered to have a cosine score above 0.65 and more than 6 matched
peaks. Further edges between two nodes were kept in the network if and only if each of the nodes
appeared in each other’s respective top 10 most similar nodes. The spectra in the network were then
searched against GNPS spectral libraries. The library spectra were filtered in the same manner as the
input data. All matches kept between network spectra and library spectra were required to have a
score above 0.65 and at least 6 matched peaks. The clustered data were downloaded and imported
into Cytoscape® (version 3.5.1, Institute for Systems Biology, Seattle, WA, USA) [68] and visualized
using import network and table, individual (selfloop) nodes without neighbors were also displayed
in molecular network. Nodes derived from the blank media and methanol blank as well as solvent
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nodes were subtracted. Self-loop nodes (single node without link to others) were also displayed in
molecular network. Venn diagram and Euler diagram were drawn by Venn and Euler Diagrams app
available as a plugin for Cytoscape®. To improve the dereplication, the in-silico MS/MS database
based on the Universal Natural Products Database (UNDP) was integrated into the MN following the
workflow from Allard et al. [16] The parent mass was selected as dereplication prefilter. Setting was as
following: Top_K_Result was used to return maximal number of results. Parameters were selected
as following: PM tolerance = 0.05, score threshold = 0.2, Top K Result = 3. Only natural products
reported isolated from fungal resources were selected as putative hits. The manual annotation was
done by using the multiple databases, such as Dictionary of Natural Products (DNP) [24], Scifinder
(https://www.cas.org/products/scifinder) [25] and Chemspider [26] based on m/z value, ppm shift.
4.7. Anticancer Activity
The crude extracts were initially tested in vitro against 6 human cancer cell lines; liver cancer
cell line HepG2 (DSMZ, Braunschweig, Germany), colorectal adenocarcinoma cell line HT-29 (DSMZ,
Braunschweig, Germany), malignant melanoma cell line A-375 (CLS, Eppelheim, Germany), colon
cancer cell line HCT-116 (DSMZ, Braunschweig, Germany), lung carcinoma cell line A549 (CLS,
Eppelheim, Germany), human breast cancer line MDA-MB-231 (CLS, Eppelheim, Germany), and the
non-cancerous human keratinocyte line HaCaT (CLS, Eppelheim, Germany) at a concentration of
200 µg/mL. The antitumoral activity of the crude extracts was evaluated by monitoring the metabolic
activity using the CellTiterBlue Cell Viability Assay (Promega, Mannheim, Germany). HepG2, HT-29
and HaCaT cells were cultivated in RPMI medium, A549 and MDA-MB-231 cells in DMEM:Ham’s
F12 medium (1:1) supplemented with 15mM HEPES and A-375 and HCT-116 cells in DMEM medium
supplemented with 4.5 g/L D-Glucose and 110 mg/L sodium pyruvate. All media were supplemented
with L-Glutamine, 10% fetal bovine serum, 100 U/mL penicillin, and 100 mg/mL streptomycin.
The cultures were maintained at 37 ◦C under a humidified atmosphere and 5% CO2. The cell lines
were transferred every 3 or 4 days. For experimental procedure, the cells were seeded in 96 well plates
at a concentration of 10,000 cells per well. A stock solution of 40 mg/mL in DMSO was prepared of
each extract. After 24 h incubation, the medium was removed from the cells and 100 µl fresh medium
containing the test samples was added. Each sample was prepared in duplicate once. Doxorubicin as a
standard therapeutic drug was used as positive control, 0.5% DMSO and growth media were used as
controls. Following compound addition, plates were cultured at 37 ◦C for 24 h. Afterwards, the assay
was performed according to the manufacturer’s instructions and measured using the microplate reader
Tecan Infinite M200 at excitation 560 nm and emission of 590 nm. For the determination of IC50 values,
a dilution series of the extracts was prepared and tested, as described before. The IC50 values were
calculated by Excel as the concentration that shows 50% inhibition of the viability on the basis of a
negative control (no compound) and compared with the positive control (doxorubicin).
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